Our research in Newcastle Upon Tyne
Newcastle is the home of one of our new Cancer Research UK Centres. The Newcastle Centre will help set the pace for national and international progress in diagnosing and treating cancer, specialising in cancers of the blood in adults and children. The Centre is jointly funded by three charities - Cancer Research UK, Leukaemia Research and the North of England Children’s Cancer Research Fund.
The Centre will concentrate on understanding the basic biology of how and why cancers develop so new drugs can be designed. Another priority will be personalised medicine, where instead of a one-size-fits-all approach, treatments are tailored to individual cancer patients' needs. This avoids unnecessary side effects and improves survival rates.
The Northern Institute for Cancer Research
The Northern Institute for Cancer Research (NICR) brings together many internationally renowned specialists in cancer research and drug development, and is co-directed by Professor Andy Hall and Professor Hilary Calvert.
By sharing their experience and expertise, scientists are able to fast-track pioneering new treatments from the lab bench to patients.
The Institute is housed in the purpose-built Paul O’Gorman building, which is named after a 14-year-old boy who lost his life to leukaemia.
The Cancer Research UK Developmental Therapeutics Unit at the Institute is an international centre for anti-cancer drug development. Here, novel treatments can be taken right through from design in the laboratory to evaluation in the clinic, so promising new treatments can benefit patients.
We fund the clinical trials work of the Children’s Cancer and Leukaemia Group (CCLG) at the Royal Victoria Infirmary in Newcastle. The group co-ordinates the care of virtually all the UK’s children with cancer, ensuring they receive the most up-to-date treatments.
Below are some of the highlights of our research in Newcastle.
All cancer types
Prof Hilary Calvert
Northern Institute for Cancer Research
Newcastle University, Newcastle Upon Tyne
Taking new cancer treatments from bench to bedside
Hilary Calvert is Professor of Medical Oncology at the Northern Institute for Cancer Research in Newcastle upon Tyne. He is one of the UK's leading cancer researchers working in drug development. Professor Calvert's team carry out clinical trials to test new anti-cancer drugs and to improve the use of existing treatments.
Prof Herbie Newell
Northern Institute for Cancer Research
University of Newcastle, Newcastle Upon Tyne
Developing new cancer treatments
Herbie Newell is Professor of Cancer Therapeutics at the Northern Institute for Cancer Research in Newcastle upon Tyne. His expertise is in cancer pharmacology - understanding how cancer drugs work inside the body. His research focuses on developing new cancer drugs and he has over 30 years experience in this area.
Lung cancer
Dr Paula Mulvenna
Northern Centre for Cancer Care
Freeman Hospital, Newcastle Upon Tyne
A clinical trial for lung cancer that has spread to the brain
Dr Paula Mulvenna is a consultant clinical oncologist who specialises in improving the quality of life for people who have cancer that cannot be cured. She is based at the Northern Centre for Cancer Care at the Freeman Hospital in Newcastle upon Tyne. Dr Mulvenna is co-ordinating a unique national clinical trial called Quartz, funded by Cancer Research UK. This trial is for people with non small cell lung cancer (NSCLC) that has spread to the brain.
Increase text
Decrease text
Print this page
